CMIC HealthCare Japan

Name

CMIC HealthCare Japan

Legal name

CMIC HealthCare Institute Co., Ltd.

Website

https://cmic-hci.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

101–250 employees

Short description

CMIC HealthCare Institute Co., Ltd. (CHI) is a Japan-based Site Management Organization (SMO) providing clinical trial support, healthcare contact center services, patient recruitment, and patient support programs to pharmaceutical companies, medical institutions, and government entities across 23 nationwide offices.

Ownership category

akta.pro rank

Product category

Clinical Trial Support Services (SMO)

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Site Network Operators & SMOs (HLAGACAA)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Site Identification & Feasibility (HLAGACAB), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Clinical trial support
• SMO services
• Patient recruitment
• Healthcare contact center
• Patient support programs

Headquarters

HQ city

Minato

HQ country

Japan

HQ region

Asia

Offices22 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. SMO (Site Management Organization) Services: CHI provides comprehensive clinical trial support services to medical institutions, including CRC (Clinical Research Coordinator) placement, SMA (Site Management Associate) support, IRB secretariat operations, and full-service clinical trial management. This is the core revenue stream and the company's historical foundation since 1999.
2. Healthcare Contact Center (Med Voice): Medical-specialized call center services for pharmaceutical companies, medical device manufacturers, and local governments. Handles drug information inquiries, safety information, patient support programs, medical consultations, and health counseling. Over 230,000 annual interactions (October 2024–September 2025).
3. Med Concierge Services (MCS): Connects medical field professionals and patients with pharmaceutical companies through interviews, focus groups, usability tests, ethics training, and survey services. Leverages a network of approximately 4,050 medical institutions and ~720 specialized staff across 23 locations.
4. Patient Support Programs (PSP): Disease education, medication adherence support, visit reminders, and high-cost medical system guidance for patients undergoing treatment. Coordinated with pharmaceutical companies and medical institutions.
5. Specific Health Guidance / Disease Prevention: Health guidance services for individuals requiring lifestyle improvement after specific health checkups, provided by registered dietitians and health nurses. Supports insurers and health insurance associations with disease prevention programs.
6. Healthcare Portal (HelC) & Advertising: Healthcare media platform generating advertising revenue from pharmaceutical companies and medical institutions. ~600,000 monthly PV and ~250,000 monthly unique visitors (September 2025). Provides disease awareness content and hospital search functionality.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

CMIC HealthCare Japan provides Site Management Organization (SMO) services for clinical trials, including study coordination, CRC staffing, and administrative support at medical institutions. The company also delivers Med Concierge contact center services, Med Reach patient recruitment, Patient Support Programs (PSP), specific health guidance and severe disease prevention services, the HelC healthcare portal, and proprietary platforms (Agatha for CHI and Clinical Trial Sync) for clinical trial document management.

Product overview

CHI operates as a comprehensive healthcare services provider offering an integrated portfolio of clinical trial support and patient engagement solutions. The core offering is SMO (治験施設支援機関) services providing full-service clinical trial support including CRC/SMA staffing, IRB secretariat operations, and document management across a network of approximately 4,050 medical institutions nationwide. This is complemented by specialized contact center services under the Med Voice (メッドボイス) brand offering GVP-compliant pharmaceutical safety information and patient support across multiple contact center types. The Med Concierge Service (MCS) enables pharmaceutical companies and medical device manufacturers to gather insights from healthcare professionals and patients through interviews, focus groups, and surveys. The Med Reach (メッドリーチ) division provides clinical trial participant recruitment combining online/offline advertising, RWD analytics with harmo pharmacy data integration, and partnerships with platforms like Ubie. Supporting services include Patient Support Programs (PSP) for adherence support, Specific Health Guidance services for lifestyle disease prevention, and the HelC healthcare portal providing disease information and hospital search to approximately 600,000 monthly page views. Document management is facilitated through Agatha for CHI (partnered with Agatha Inc.) and Clinical Trial Sync (jointly developed with DNP). The company also advances patient-centered trial design through PPI (Patient and Public Involvement) initiatives, including the children's clinical trial educational material "ちけんのえほん" launched in March 2026.

Differentiator

Problem solved

Functional benefit

Brands

• Med Voice: Contact center services for healthcare and medical companies, providing patient support, drug information, and medical device inquiry handling
• Med Reach
• Med Concierge
• Agatha for CHI
• Clinical Trial Sync
• HelC
• SSI
• ちけんのえほん
• Trial Navi

Products and services

• SMO (Site Management Organization) Services Site Management Organization services for pharmaceutical-sponsored clinical trials in Japan, including placement of clinical research coordinators (CRCs) at medical institutions, protocol execution support, and on-site administrative services. Customers are pharmaceutical sponsors and the 4,050 medical institutions in CHI's network.
• Med Concierge Service (MCS)

Quantifiable outcome

• ePRO input rate improved from 20% to 90% through contact center support
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability2 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered secondary and core.

• 患者会 (Patient Associations)secondaryStrategic or Co-development Partner · 12 March 2026CHI collaborates with patient associations to support clinical trial recruitment by disseminating trial information to patients in specific therapeutic areas. This PPI (Patient and Public Involvement) approach helps communicate trial details appropriately to patients and supports informed participation decisions.
• 大日本印刷株式会社 (DNP)coreStrategic or Co-development Partner · 9 January 2026CHI and DNP (Dai Nippon Printing) co-developed the 'Clinical Trial Sync' cloud service for clinical trial document management. This partnership enables efficient document sharing and management among medical institutions, sponsors, and IRBs. DNP contributes printing, document management, and IT infrastructure expertise while CHI provides clinical trial operational knowledge and medical institution access. The service supports the coming single-IRB era in Japan.
• 大手保険グループ会社 (Major Insurance Group)secondaryStrategic or Co-development Partner · 1 August 2025CHI partners with a major insurance company to recruit clinical trial participants through the 'Trial Navi' website targeting insurance policyholders. Launched in August 2025 as a demonstration project, this initiative targets cancer patients with high medical awareness among insurance subscribers, leveraging insurance claim data to identify potential trial participants.
• Ubie株式会社 (Ubie Co., Ltd.)coreStrategic or Co-development PartnerCHI partners with Ubie to leverage their medical platform (with 12M+ monthly users including the symptom search engine 'Yubi' and disease Q&A) for clinical trial participant recruitment. The partnership enables targeted recruitment by identifying potential patients through symptom search data and delivering trial information through natural user pathways, reaching populations difficult to access through traditional advertising.
• アガサ株式会社 (Agatha Inc.)coreTechnology or IntegrationCHI partnered with Agatha Inc. to offer 'Agatha for CHI,' a cloud-based clinical trial document management system optimized for medical institutions. Agatha provides the underlying document management platform while CHI offers implementation support, operational assistance, and integration with their SMO services. Over 460 medical institutions have adopted this system.
• harmo株式会社 (harmo Co., Ltd.)coreStrategic or Co-development PartnerCHI partners with harmo to leverage their real-world data (RWD) including up to 25 million prescription claim records for clinical trial site selection. This 'RWD-driven' recruitment model enables 'area screening' by visualizing where target patients receive treatment, allowing CHI to identify optimal referral sites based on patient geography rather than relying on historical experience.
• 新潟大学 (Niigata University)secondaryStrategic or Co-development PartnerCHI and Niigata University began a joint research initiative in March 2025 utilizing harmo's electronic medication record (お薬手帳) data for clinical research applications.

Scale indicators8 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• ICON plc: ICON is a global CRO providing clinical research services including site management across multiple geographies including Japan. As a broad incumbent, ICON competes with CHI for multi-region pharmaceutical trial work rather than Japan-specific SMO specialization.
• IQVIA Japan: IQVIA is a global CRO/SMO incumbent with significant Japan operations providing clinical trial services, real-world data, and commercial solutions. While not specialized in Japan's SMO niche, IQVIA competes for global pharma trials run in Japan and adjacent services like RWD analytics.
• Medipal Holdings: Medipal Holdings is a Japanese pharmaceutical distribution and healthcare services conglomerate with overlapping services in patient support programs and healthcare contact center operations. While primarily a wholesaler, its healthcare services segment competes with CHI's patient engagement offerings.

Emerging players

• Medrio: Medrio is an eClinical technology provider offering electronic data capture and clinical trial management solutions. While focused on technology rather than services, it overlaps with CHI's Clinical Trial Sync and Agatha platforms in enabling digital trial operations.
• Medical Data Vision: Medical Data Vision is a Japanese health data company providing real-world data and analytics to pharmaceutical companies. It overlaps with CHI's harmo-based RWD recruitment capabilities and competes for data-driven clinical trial optimization services in Japan.

Direct peers

• Soiken Holdings: Soiken is a Japanese clinical research support organization providing SMO services and specific health guidance programs. It directly competes with CHI in Japan's SMO market while also overlapping in the health guidance/disease prevention services segment.
• EPS Holdings: EPS Holdings is Japan's largest domestic CRO/SMO group and CHI's primary direct competitor in the Japanese clinical trial services market. Both companies operate extensive SMO networks supporting pharmaceutical sponsors with site management and CRC placement, with EPS competing head-to-head for trial contracts at major Japanese medical institutions.
• InCROM (formerly InCROM JP): InCROM is a Japanese SMO and CRO providing clinical trial support services to pharmaceutical companies and medical institutions. It competes with CHI in the same Japanese SMO market segment with overlapping service portfolios including CRC staffing and clinical research coordination.
• A2 Healthcare Corporation: A2 Healthcare is a leading Japanese SMO providing clinical trial site management and patient recruitment services. It is directly comparable to CHI as a domestic SMO serving the same pharmaceutical sponsor base with similar CRC placement and IRB support offerings.
• I'rom Holdings: I'rom Holdings is a Japanese group providing SMO services, clinical trial support, and healthcare staffing. It competes with CHI for pharmaceutical sponsor contracts and medical institution partnerships across Japan's clinical trial ecosystem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php?id=61576713612835
• Instagraminstagram.com/cmic_healthcare

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CMIC HealthCare Japan